Tenaya Therapeutics Inc (TNYA) Earnings Report, Financial Results, Financial analysis

Tenaya Therapeutics Inc narrowed IV. Quarter net loss per share of $-0.48 compare to net loss per share of $-0.68 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.74 realized in previous quarter.

*IV. Quarter*
Earnings Per Share	Revenues
$ -0.48	$ 0 Mill
$+0.20	Unch.

Tenaya Therapeutics Inc 's Revenue fell by 0 % in IV. Quarter (Dec 31 2022) year on year, to $0 million and declined by sequentially.

Tenaya Therapeutics Inc is Expected to report next financial results on May 10, 2023.

More on TNYA's Income Statement

TNYA's NET INCOME

Tenaya Therapeutics Inc 's in IV. Quarter recorded net loss of $-33.516 million, an increase from net loss of $-18.262 million in III. Quarter a year ago.

Sequentially net loss advanced

More on TNYA's Growth

Tenaya Therapeutics Inc Inventories
TNYA's Cash flow In IV. Quarter company's net cash flow was $4 million

Earnings quality

Tenaya Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Tenaya Therapeutics Inc payed $ -2.33 cash per share, on a free-cash flow basis .

Book value grew by 14.42 % sequentially to $5.43 per share.
Tangible Book value grew to $ 5.43 per share from $ 4.75.

Company issued 3.45 million shares or 8.34 % in IV. Quarter.

• More on TNYA's Dividends

Market Capitalization (Millions)	128
Shares Outstanding (Millions)	45
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-124
Cash Flow (TTM) (Millions $)	0
Capital Exp. (TTM) (Millions $)	-20
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Tenaya Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Tenaya Therapeutics Inc had negative $ -2.33 cash flow per share, on a free-cash flow basis .

Book value grew by 14.42 % sequentially to $5.43 per share.
Tangible Book value grew to $ 5.43 per share from $ 4.75.

Company issued 3.45 million shares or 8.34 % in IV. Quarter.

• More on TNYA's Balance Sheets

Market Capitalization (Millions)	128
Shares Outstanding (Millions)	45
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-124
Cash Flow (TTM) (Millions $)	0
Capital Exp. (TTM) (Millions $)	-20
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar QTNT's Profile Stock Price QTNT's Financials Business Description Fundamentals Charts & Quotes QTNT's News Suppliers QTNT's Competitors Customers & Markets Economic Indicators QTNT's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Tenaya Therapeutics Inc

TNYA's Financial Statements and Analysis